Starting Salary from £28,500 to £38,000 (Depending on experience)
Initial 3 year fixed term contract.

Cancer Research UK Beatson Institute in Glasgow is one of Europe's leading cancer research centres. It supports cutting edge research into the molecular mechanisms of cancer development. The Institute provides an outstanding research environment, underpinned by state-of-the-art core services and advanced technologies.

This post is funded through a multi-faceted industrial collaboration and will investigate the role of RAC and RAL-GTPases in both CRC and PDAC. It will involve close interaction with team members across multiple sites.

Imaging GTPase activation in cancer
Prof Kurt I. Anderson

The Tumour Cell Migration Laboratory led by Professor Kurt I. Anderson has pioneered the use of imaging methods (FRAP and FLIM-FRET) to assess pharmacodynamics in vivo (Serrels et al. (2009) Cancer Res 69:2714; Timpson et al. (2011) Cancer Res 71:747; Nobis et al. (2013) Cancer Res 73:4674).

We now seek a highly motivated and dedicated postdoctoral researcher to develop the use of FRET probes to read out GTPase activation in pancreatic cancer models. You will use imaging, molecular biology, and biochemical methods to optimize FRET probe performance, followed by use of the optimised probes to characterise mechanistic cancer models in vitro and in vivo. A relevant PhD is required and in depth knowledge of cancer biology and/or imaging would be advantageous.

Informal enquiries or applications with covering letter, CV, and names of three referees should be sent to Prof Kurt I. Anderson, Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK or by email to k.anderson@beatson.gla.ac.uk via the APPLY button below.

Closing date for applications: 28^th February 2014